Delivery Order SPE2DX22D0010-SPE2D826FCB85
Award Date 12/30/25
Potential Completion Date 12/31/25
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,280.65 to AmerisourceBergen Drug Corp for the supply of Oxymorphone HCL ER Tablets 20mg, with an ultimate completion date of December 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp was awarded a delivery order on October 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Oxymorphone HCL ER Tablets 20mg with a ceiling value of $5,773.98. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, a controlled-release pain management pharmaceutical. This non-set-aside, competitively awarded delivery order has a ceiling value of $15,791.14 and a firm fixed-price structure, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- On September 25, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,331.03 to AmerisourceBergen Drug Corp for the supply of Oxymorphone HCL ER Tablets 10mg. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance of this order is scheduled for completion by September 26, 2025, at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, with a contract ceiling value of $3,394.93 and an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania—the designated place of performance....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,198.34 to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count supply). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 2, 2025. The award was issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, valued at $11,133.62. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's continued capability...
- This delivery order, awarded on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides Oxymorphone HCL ER Tablets 40mg with a ceiling value of $2,062.57. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger...